National Health Investors (NYSE:NHI) PT Lowered to $51.00 at Wells Fargo & Co
National Health Investors (NYSE:NHI) had its price objective dropped by Wells Fargo & Co from $82.00 to $51.00 in a research report issued on Thursday, BenzingaRatingsTable reports. The firm presently has an “equal weight” rating on the real estate investment trust’s stock. Wells Fargo & Co‘s price target suggests a potential downside of 1.75% from the company’s current price.
A number of other analysts have also recently weighed in on the stock. Mizuho reissued a “buy” rating and set a $95.00 price objective on shares of National Health Investors in a report on Friday, December 20th. Berenberg Bank assumed coverage on shares of National Health Investors in a research note on Wednesday, February 5th. They issued a “buy” rating and a $94.00 price objective on the stock. Finally, BMO Capital Markets upgraded shares of National Health Investors from an “underperform” rating to a “market perform” rating and boosted their target price for the stock from $74.00 to $82.00 in a research report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $82.40.
National Health Investors stock traded up $3.14 during midday trading on Thursday, hitting $51.91. 9,540 shares of the stock were exchanged, compared to its average volume of 601,443. National Health Investors has a fifty-two week low of $31.37 and a fifty-two week high of $91.12. The stock has a market capitalization of $1.91 billion, a price-to-earnings ratio of 14.05 and a beta of 0.35. The stock’s 50-day simple moving average is $74.37 and its 200 day simple moving average is $80.39. The company has a current ratio of 16.40, a quick ratio of 16.40 and a debt-to-equity ratio of 0.96.
In related news, Director Robert T. Webb purchased 2,151 shares of the firm’s stock in a transaction on Monday, March 16th. The stock was purchased at an average price of $46.28 per share, for a total transaction of $99,548.28. Following the acquisition, the director now directly owns 63,339 shares in the company, valued at $2,931,328.92. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director W Andrew Adams purchased 27,000 shares of the firm’s stock in a transaction on Monday, March 23rd. The stock was bought at an average price of $36.16 per share, with a total value of $976,320.00. Following the acquisition, the director now owns 759,784 shares in the company, valued at $27,473,789.44. The disclosure for this purchase can be found here. 5.11% of the stock is currently owned by corporate insiders.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Norges Bank acquired a new position in shares of National Health Investors in the 4th quarter valued at $43,207,000. Bank of New York Mellon Corp increased its position in National Health Investors by 32.3% during the fourth quarter. Bank of New York Mellon Corp now owns 793,760 shares of the real estate investment trust’s stock worth $64,675,000 after purchasing an additional 193,903 shares during the last quarter. Kennedy Capital Management Inc. increased its position in National Health Investors by 97.9% during the fourth quarter. Kennedy Capital Management Inc. now owns 243,381 shares of the real estate investment trust’s stock worth $19,831,000 after purchasing an additional 120,383 shares during the last quarter. Marshall Wace LLP increased its position in National Health Investors by 19,516.1% during the fourth quarter. Marshall Wace LLP now owns 83,957 shares of the real estate investment trust’s stock worth $6,841,000 after purchasing an additional 83,529 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in National Health Investors by 9.5% during the fourth quarter. Geode Capital Management LLC now owns 610,121 shares of the real estate investment trust’s stock worth $49,712,000 after purchasing an additional 53,107 shares during the last quarter. Hedge funds and other institutional investors own 70.65% of the company’s stock.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Read More: Trading Ex-Dividend
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.